Cargando…
Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia
Escape from chemotherapy-induced apoptosis is a hallmark of drug resistance in cancer. The recent identification of alternative programmed cell death pathways opens up for possibilities to circumvent the apoptotic blockade in drug resistant cancer and eliminate malignant cells. Indeed, we have recen...
Autores principales: | Mezzatesta, Caterina, Bornhauser, Beat C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433701/ https://www.ncbi.nlm.nih.gov/pubmed/30941349 http://dx.doi.org/10.3389/fcell.2019.00040 |
Ejemplares similares
-
Epigenetic Priming in Childhood Acute Lymphoblastic Leukemia
por: Raboso-Gallego, Javier, et al.
Publicado: (2019) -
Editorial: Biomarkers and therapeutic strategies in acute lymphoblastic leukemia
por: Lee, Ki-Young, et al.
Publicado: (2023) -
Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia
por: Ogana, Heather A., et al.
Publicado: (2023) -
The progress in the relationship between trace elements and acute lymphoblastic leukemia
por: Wang, Jing, et al.
Publicado: (2023) -
Characterization of mesenchymal stem cells in pre-B acute lymphoblastic leukemia
por: Hughes, Anastasia M., et al.
Publicado: (2023)